CFA
GEVA

CT Financial Advisors’s SYNAGEVA BIOPHARMA CORP COM STK (DE) GEVA Stock Holding History

CT Financial Advisors’s Portfolio GEVA Stock Details GEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-200
Closed -$19.5K – 657
2015
Q1 		$19.5K Buy
+200
New +$21.2K 0.01% 393
2014
Q1 		$19.5K Buy
+200
New +$18.5K 0.01% 393

CT Financial Advisors's GEVA Position: Q2 2015 in Review

CT Financial Advisors sold out of SYNAGEVA BIOPHARMA CORP COM STK (DE) (GEVA) in Q2 2015, closing a stake of 200 shares — an estimated $19.5K sold.

CT Financial Advisors first reported a position in GEVA in Q1 2014 and held it in 2 quarters. The position peaked at $19.5K in Q1 2015. 0 funds tracked by Wall St. Rank hold GEVA as of Q2 2015.

  • CT Financial Advisors reported no remaining SYNAGEVA BIOPHARMA CORP COM STK (DE) position as of Q2 2015 after selling out during the quarter.
  • CT Financial Advisors sold 200 SYNAGEVA BIOPHARMA CORP COM STK (DE) shares in Q2 2015, an estimated $19.5K.
  • CT Financial Advisors first reported a position in SYNAGEVA BIOPHARMA CORP COM STK (DE) in Q1 2014 and held it in 2 quarters.
  • CT Financial Advisors's SYNAGEVA BIOPHARMA CORP COM STK (DE) position peaked at $19.5K in Q1 2015.
  • 0 funds tracked by Wall St. Rank held SYNAGEVA BIOPHARMA CORP COM STK (DE) as of Q2 2015.

Based on CT Financial Advisors's 13F filing for Q2 2015, filed 17 Jul 2015.